Northern Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $96.5M | Buy |
1,748,557
+48,344
| +3% | +$2.62M | 0.01% | 759 |
|
|
2025
Q4 | $83.4M | Sell |
1,700,213
-581,650
| -25% | -$27.1M | 0.01% | 813 |
|
|
2025
Q3 | $98.5M | Buy |
2,281,863
+166,534
| +8% | +$6.51M | 0.01% | 751 |
|
|
2025
Q2 | $81.2M | Sell |
2,115,329
-50,555
| -2% | -$1.93M | 0.01% | 818 |
|
|
2025
Q1 | $83.9M | Buy |
2,165,884
+105,629
| +5% | +$3.87M | 0.01% | 785 |
|
|
2024
Q4 | $69.7M | Buy |
2,060,255
+287,211
| +16% | +$10.3M | 0.01% | 927 |
|
|
2024
Q3 | $72.5M | Buy |
1,773,044
+76,521
| +5% | +$3.13M | 0.01% | 806 |
|
|
2024
Q2 | $65.3M | Sell |
1,696,523
-18,609
| -1% | -$783K | 0.01% | 834 |
|
|
2024
Q1 | $73.5M | Sell |
1,715,132
-18,429
| -1% | -$760K | 0.01% | 765 |
|
|
2023
Q4 | $64.2M | Buy |
1,733,561
+84,683
| +5% | +$3.04M | 0.01% | 835 |
|
|
2023
Q3 | $59.8M | Buy |
1,648,878
+173,748
| +12% | +$6.17M | 0.01% | 823 |
|
|
2023
Q2 | $52.6M | Buy |
1,475,130
+53,406
| +4% | +$1.92M | 0.01% | 937 |
|
|
2023
Q1 | $50.6M | Sell |
1,421,724
-4,921
| -0.3% | -$172K | 0.01% | 941 |
|
|
2022
Q4 | $50.1M | Sell |
1,426,645
-52,655
| -4% | -$1.75M | 0.01% | 922 |
|
|
2022
Q3 | $43.5M | Sell |
1,479,300
-18,560
| -1% | -$703K | 0.01% | 938 |
|
|
2022
Q2 | $81.5M | Sell |
1,497,860
-12,719
| -0.8% | -$702K | 0.02% | 634 |
|
|
2022
Q1 | $82.3M | Sell |
1,510,579
-157,987
| -9% | -$8.58M | 0.01% | 719 |
|
|
2021
Q4 | $92M | Buy |
1,668,566
+166,854
| +11% | +$8.68M | 0.02% | 701 |
|
|
2021
Q3 | $71.7M | Sell |
1,501,712
-156,092
| -9% | -$7.84M | 0.01% | 832 |
|
|
2021
Q2 | $82.5M | Sell |
1,657,804
-404,483
| -20% | -$19.4M | 0.01% | 773 |
|
|
2021
Q1 | $92M | Buy |
2,062,287
+94,380
| +5% | +$4.28M | 0.02% | 712 |
|
|
2020
Q4 | $90.5M | Sell |
1,967,907
-92,183
| -4% | -$4.23M | 0.02% | 687 |
|
|
2020
Q3 | $96.9M | Buy |
2,060,090
+8,976
| +0.4% | +$450K | 0.02% | 573 |
|
|
2020
Q2 | $105M | Sell |
2,051,114
-103,349
| -5% | -$5.3M | 0.02% | 526 |
|
|
2020
Q1 | $102M | Sell |
2,154,463
-55,912
| -3% | -$2.98M | 0.03% | 469 |
|
|
2019
Q4 | $130M | Buy |
2,210,375
+39,291
| +2% | +$2.19M | 0.03% | 499 |
|
|
2019
Q3 | $116M | Buy |
2,171,084
+59,650
| +3% | +$3.07M | 0.03% | 517 |
|
|
2019
Q2 | $106M | Sell |
2,111,434
-8,902
| -0.4% | -$447K | 0.03% | 555 |
|
|
2019
Q1 | $111M | Sell |
2,120,336
-126,041
| -6% | -$6.3M | 0.03% | 522 |
|
|
2018
Q4 | $107M | Sell |
2,246,377
-110,485
| -5% | -$5.44M | 0.03% | 494 |
|
|
2018
Q3 | $118M | Buy |
2,356,862
+59,480
| +3% | +$3.02M | 0.03% | 496 |
|
|
2018
Q2 | $116M | Sell |
2,297,382
-267,949
| -10% | -$13.5M | 0.03% | 512 |
|
|
2018
Q1 | $125M | Buy |
2,565,331
+245,153
| +11% | +$11.4M | 0.03% | 485 |
|
|
2017
Q4 | $103M | Sell |
2,320,178
-136,942
| -6% | -$6.33M | 0.03% | 557 |
|
|
2017
Q3 | $125M | Sell |
2,457,120
-5,662
| -0.2% | -$287K | 0.03% | 484 |
|
|
2017
Q2 | $133M | Buy |
2,462,782
+68,664
| +3% | +$3.66M | 0.04% | 445 |
|
|
2017
Q1 | $126M | Buy |
2,394,118
+25,780
| +1% | +$1.31M | 0.04% | 449 |
|
|
2016
Q4 | $114M | Buy |
2,368,338
+744,795
| +46% | +$36.8M | 0.04% | 464 |
|
|
2016
Q3 | $87.5M | Buy |
1,623,543
+30,749
| +2% | +$1.69M | 0.03% | 553 |
|
|
2016
Q2 | $86.3M | Sell |
1,592,794
-172,351
| -10% | -$9.08M | 0.03% | 542 |
|
|
2016
Q1 | $89.4M | Buy |
1,765,145
+48,195
| +3% | +$2.4M | 0.03% | 531 |
|
|
2015
Q4 | $86.6M | Sell |
1,716,950
-96,036
| -5% | -$4.9M | 0.03% | 528 |
|
|
2015
Q3 | $87.1M | Buy |
1,812,986
+111,684
| +7% | +$5.81M | 0.03% | 523 |
|
|
2015
Q2 | $88.6M | Buy |
1,701,302
+71,216
| +4% | +$4.01M | 0.03% | 551 |
|
|
2015
Q1 | $94M | Buy |
1,630,086
+120,489
| +8% | +$6.91M | 0.03% | 538 |
|
|
2014
Q4 | $80.7M | Buy |
1,509,597
+494,622
| +49% | +$27.7M | 0.02% | 576 |
|
|
2014
Q3 | $58.3M | Sell |
1,014,975
-1,759,924
| -63% | -$108M | 0.02% | 690 |
|
|
2014
Q2 | $186M | Buy |
2,774,899
+781,917
| +39% | +$52.9M | 0.06% | 317 |
|
|
2014
Q1 | $133M | Buy |
1,992,982
+347,895
| +21% | +$23.5M | 0.04% | 400 |
|
|
2013
Q4 | $110M | Buy |
1,645,087
+37,405
| +2% | +$2.43M | 0.04% | 439 |
|
|
2013
Q3 | $101M | Buy |
1,607,682
+33,844
| +2% | +$2.18M | 0.04% | 441 |
|
|
2013
Q2 | $98.3M | Buy |
+1,573,838
| New | +$99.9M | 0.04% | 432 |
|
Other funds holding GSK
JEST
Northern Trust's GSK Position: Q1 2026 in Review
Northern Trust increased its GSK (GSK) stake by 2.8% in Q1 2026, buying an estimated $2.62M and bringing the position to 1,748,557 shares worth $96.5M. The position accounts for 0.01% of the portfolio, ranked #759.
Northern Trust first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $186M in Q2 2014. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Northern Trust held 1,748,557 shares of GSK worth $96.5M as of Q1 2026.
- Northern Trust bought 48,344 GSK shares in Q1 2026, an estimated $2.62M.
- GSK made up 0.01% of Northern Trust's portfolio in Q1 2026, its #759 holding.
- Northern Trust first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's GSK position peaked at $186M in Q2 2014.
- 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.